Arizona State Retirement System Boosts Position in Mylan N.V. (NASDAQ:MYL)
Arizona State Retirement System boosted its position in shares of Mylan N.V. (NASDAQ:MYL) by 0.3% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 114,308 shares of the company’s stock after buying an additional 300 shares during the period. Arizona State Retirement System’s holdings in Mylan N.V. were worth $4,437,000 at the end of the most recent reporting period.
Other hedge funds have also recently bought and sold shares of the company. First Personal Financial Services boosted its stake in shares of Mylan N.V. by 33.2% in the first quarter. First Personal Financial Services now owns 2,733 shares of the company’s stock worth $107,000 after buying an additional 681 shares during the last quarter. Global X Management Co. LLC boosted its stake in shares of Mylan N.V. by 91.6% in the first quarter. Global X Management Co. LLC now owns 3,015 shares of the company’s stock worth $118,000 after buying an additional 1,441 shares during the last quarter. Ropes Wealth Advisors LLC bought a new stake in shares of Mylan N.V. during the first quarter worth approximately $136,000. Oakworth Capital Inc. boosted its stake in shares of Mylan N.V. by 30.7% in the first quarter. Oakworth Capital Inc. now owns 4,255 shares of the company’s stock worth $166,000 after buying an additional 1,000 shares during the last quarter. Finally, State of Alaska Department of Revenue bought a new stake in shares of Mylan N.V. during the first quarter worth approximately $188,000. Institutional investors own 71.57% of the company’s stock.
Mylan N.V. (NASDAQ MYL) opened at 29.63 on Tuesday. Mylan N.V. has a 52 week low of $29.56 and a 52 week high of $49.42. The company’s 50-day moving average price is $37.07 and its 200-day moving average price is $39.00. The company has a market capitalization of $15.89 billion, a price-to-earnings ratio of 23.95 and a beta of 1.27.
Mylan N.V. (NASDAQ:MYL) last posted its quarterly earnings data on Wednesday, August 9th. The company reported $1.10 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.18 by $0.08. Mylan N.V. had a return on equity of 22.42% and a net margin of 5.51%. The firm had revenue of $2.96 billion for the quarter, compared to analysts’ expectations of $3 billion. During the same quarter last year, the firm posted $1.16 earnings per share. Mylan N.V.’s quarterly revenue was up 15.7% on a year-over-year basis. Equities analysts forecast that Mylan N.V. will post $4.64 earnings per share for the current fiscal year.
A number of analysts have commented on MYL shares. Royal Bank Of Canada restated a “sector perform” rating and issued a $46.00 price target (down previously from $48.00) on shares of Mylan N.V. in a research report on Monday, April 17th. Deutsche Bank AG reduced their price target on Mylan N.V. from $52.00 to $51.00 and set a “buy” rating for the company in a research report on Tuesday, April 18th. BMO Capital Markets started coverage on Mylan N.V. in a research report on Monday, May 1st. They issued an “outperform” rating and a $50.00 price target for the company. Zacks Investment Research cut Mylan N.V. from a “hold” rating to a “sell” rating in a research report on Monday, May 15th. Finally, Cowen and Company restated a “market perform” rating and issued a $43.00 price target (down previously from $55.00) on shares of Mylan N.V. in a research report on Sunday, May 21st. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the stock. Mylan N.V. has an average rating of “Buy” and a consensus price target of $47.83.
In other news, insider Anthony Mauro sold 10,000 shares of the company’s stock in a transaction that occurred on Friday, June 9th. The stock was sold at an average price of $40.00, for a total value of $400,000.00. Following the completion of the sale, the insider now directly owns 140,653 shares in the company, valued at $5,626,120. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, President Rajiv Malik sold 25,000 shares of the company’s stock in a transaction that occurred on Friday, June 9th. The shares were sold at an average price of $40.00, for a total value of $1,000,000.00. Following the completion of the sale, the president now owns 799,855 shares of the company’s stock, valued at $31,994,200. The disclosure for this sale can be found here. 0.69% of the stock is currently owned by insiders.
Mylan N.V. Company Profile
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan N.V. (NASDAQ:MYL).
Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.